Breaking News Instant updates and real-time market news.

MRNA

Moderna

$24.10

-1.73 (-6.70%)

04:55
04/17/19
04/17
04:55
04/17/19
04:55

Moderna management to meet with Needham

Meeting to be held in Toronto on April 17 hosted by Needham.

  • 17

    Apr

  • 07

    May

  • 08

    May

MRNA Moderna
$24.10

-1.73 (-6.70%)

01/22/19
PIPR
01/22/19
NO CHANGE
Target $24
PIPR
Overweight
Translate clinical hold has no read-through to Moderna, says Piper Jaffray
Moderna's (MRNA) messenger RNA competitor Translate Bio (TBIO) announced this morning that the FDA placed a clinical hold on its Investigational New Drug Application for MRT5201 to treat ornithine transcarbamylase deficiency, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. Translate Bio also had a prior clinical IND hold on MRT5005 for cystic fibrosis due to manufacturing issues, adds the analyst. Tenthoff does not see read-through to Moderna's mRNA platform and pipeline from the news. The FDA accepted the company's IND for mRNA-3704 to treat orphan disease methylmalonic acidemia, and the Phase I/II study will begin soon, says the analyst. He reiterates an Overweight rating on Moderna with a $24 price target. The stock in midday trading is down 3% to $16.15.
02/04/19
PIPR
02/04/19
NO CHANGE
Target $24
PIPR
Overweight
Piper a buyer of Moderna ahead of Phase 1 mRNA-1944 data
Piper Jaffray analyst Edward Tenthoff is a buyer of Moderna ahead of the Phase I data on mRNA-1944 chikungunya virus antibody in the first half of 2019. While the analyst ascribes no value for mRNA-1944 itself, he believes these data will have important read-through to Moderna's emerging Orphan Disease pipeline. mRNA-1944 is Moderna's first systemic secreted mRNA therapeutic and will validate mRNA-3704 for methylmalonic acidemia, mRNA-3927 for propionic acidemi, mRNA-3283 for phenylketonuria, mRNA-3630 for Fabry's disease and several as yet undisclosed orphan disease programs, Tenthoff tells investors in a research note. The analyst keeps an Overweight rating on Moderna with a $24 price target.
02/05/19
PIPR
02/05/19
NO CHANGE
Target $24
PIPR
Overweight
Piper says Moderna mRNA-1944 data has important read-through to rest of pipeline
After Moderna announced the dosing of the first subject in a Phase 1 clinical trial evaluating the safety and tolerability of escalating doses of mRNA-1944, Piper Jaffray analyst Edward Tenthoff said he sees an important read-through from this data, expected in the first half of 2019, to the rest of Moderna's orphan disease pipeline. The analyst, who thinks mRNA technology is ideally suited to address short-comings of Enzyme Replacement Therapy, keeps an Overweight rating and $24 price target on Moderna shares.
04/05/19
CHDN
04/05/19
INITIATION
Target $40
CHDN
Buy
Moderna initiated with a Buy at Chardan
Chardan analyst Gbola Amusa initiated Moderna (MRNA) with a Buy and $40 price target telling investors the company's therapeutics have potential utility across a spectrum of diseases given they can direct cells to produce intracellular, membrane, or secreted proteins. After demonstrating preclinical and clinical proof-of-concept in a number indications, Moderna has attracted the attention of big biopharma and has ongoing validating and de-risking collaborations with Merck & Co (MRK) and AstraZeneca (AZN).

TODAY'S FREE FLY STORIES

GOLD

Barrick Gold

$13.20

-0.06 (-0.45%)

, NEM

Newmont Mining

$34.18

-0.58 (-1.67%)

07:07
04/18/19
04/18
07:07
04/18/19
07:07
Hot Stocks
Barrick Gold reports preliminary Q1 sales of 1.37M ounces of gold »

After setting a…

GOLD

Barrick Gold

$13.20

-0.06 (-0.45%)

NEM

Newmont Mining

$34.18

-0.58 (-1.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

POOL

Pool Corp.

$169.00

-1.63 (-0.96%)

07:07
04/18/19
04/18
07:07
04/18/19
07:07
Earnings
Pool Corp. reports Q1 ex-items EPS 59c, consensus 65c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 01

    May

  • 05

    Jun

  • 13

    Nov

ACB

Aurora Cannabis

$8.95

0.11 (1.24%)

07:06
04/18/19
04/18
07:06
04/18/19
07:06
Hot Stocks
Aurora Cannabis provides update on German cannabis production tender »

Aurora Cannabis confirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$47.39

-0.06 (-0.13%)

07:06
04/18/19
04/18
07:06
04/18/19
07:06
Earnings
Schlumberger reports Q1 EPS 30c, consensus 30c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 06

    May

  • 22

    May

  • 13

    Nov

SNGX

Soligenix

$0.83

0.03 (3.75%)

07:06
04/18/19
04/18
07:06
04/18/19
07:06
Hot Stocks
Soligenix reaches enrollment milestone in Phase 3 trial of SGX942 »

Soligenix has reached an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$85.49

-0.71 (-0.82%)

07:05
04/18/19
04/18
07:05
04/18/19
07:05
Hot Stocks
Breaking Hot Stocks news story on Philip Morris »

Philip Morris still sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 01

    May

  • 06

    May

RCI

Rogers Communications

$53.15

-0.14 (-0.26%)

07:04
04/18/19
04/18
07:04
04/18/19
07:04
Earnings
Rogers Communications reports Q1 adj. EPS C$0.78 vs. C$0.90 last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 14

    May

  • 23

    May

DWDP

DowDuPont

$39.20

-0.04 (-0.10%)

07:04
04/18/19
04/18
07:04
04/18/19
07:04
Hot Stocks
DowDuPont provides update on Q1 performance »

DowDuPont is providing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 29

    May

BX

Blackstone

$35.91

-0.08 (-0.22%)

07:04
04/18/19
04/18
07:04
04/18/19
07:04
Hot Stocks
Blackstone announces conversion to corporation »

Blackstone Chairman and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 11

    Jun

PM

Philip Morris

$85.49

-0.71 (-0.82%)

07:04
04/18/19
04/18
07:04
04/18/19
07:04
Earnings
Philip Morris sees FY19 reported EPS at least $4.87, consensus $5.09 »

This full-year guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 01

    May

  • 06

    May

WTR

Aqua America

$34.83

-1.075 (-2.99%)

07:03
04/18/19
04/18
07:03
04/18/19
07:03
Syndicate
Aqua America 32.5M share Secondary priced at $34.62 »

Goldman Sachs, RBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 18

    Apr

PM

Philip Morris

$85.49

-0.71 (-0.82%)

07:01
04/18/19
04/18
07:01
04/18/19
07:01
Earnings
Philip Morris reports Q1 adjusted EPS $1.09, consensus 97c »

Reports Q1 revenue $6.8B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 01

    May

  • 06

    May

TRV

Travelers

$135.89

-2.48 (-1.79%)

07:01
04/18/19
04/18
07:01
04/18/19
07:01
Hot Stocks
Travelers raises quarterly dividend 6.5% to 82c per share »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

LVS

Las Vegas Sands

$67.90

-0.205 (-0.30%)

, WYNN

Wynn Resorts

$143.35

-1.37 (-0.95%)

07:01
04/18/19
04/18
07:01
04/18/19
07:01
Recommendations
Las Vegas Sands, Wynn Resorts, Melco Resorts & Entertainment analyst commentary  »

Las Vegas Sands price…

LVS

Las Vegas Sands

$67.90

-0.205 (-0.30%)

WYNN

Wynn Resorts

$143.35

-1.37 (-0.95%)

MLCO

Melco Resorts & Entertainment

$26.43

0.52 (2.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 16

    May

  • 29

    May

INN

Summit Hotel Properties

$11.64

0.01 (0.09%)

07:00
04/18/19
04/18
07:00
04/18/19
07:00
Hot Stocks
Summit Hotel Properties sells 6 hotels for $135M »

Summit Hotel Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 16

    May

  • 16

    May

07:00
04/18/19
04/18
07:00
04/18/19
07:00
General news
European stock markets are trading mixed, »

European stock markets…

TRV

Travelers

$135.89

-2.48 (-1.79%)

06:59
04/18/19
04/18
06:59
04/18/19
06:59
Hot Stocks
Travelers reports consolidated combined ratio of 93.7% »

Reports underlying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

TRV

Travelers

$135.89

-2.48 (-1.79%)

06:58
04/18/19
04/18
06:58
04/18/19
06:58
Hot Stocks
Travelers reports book value per share $92.94, up 7% from year-end 2018 »

Reports adjusted book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

TRV

Travelers

$135.89

-2.48 (-1.79%)

06:57
04/18/19
04/18
06:57
04/18/19
06:57
Hot Stocks
Breaking Hot Stocks news story on Travelers »

Travelers raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

CTG

Computer Task Group

$4.27

0.02 (0.47%)

06:57
04/18/19
04/18
06:57
04/18/19
06:57
Earnings
Computer Task Group backs FY19 non-GAAP EPS view 30c-40c, consensus 33c »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

SNAP

Snap

$11.75

0.08 (0.69%)

06:57
04/18/19
04/18
06:57
04/18/19
06:57
Downgrade
Snap rating change  »

Snap downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

TRV

Travelers

$135.89

-2.48 (-1.79%)

06:57
04/18/19
04/18
06:57
04/18/19
06:57
Earnings
Travelers reports Q1 core EPS $2.83, consensus $2.74 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

FSLR

First Solar

$60.70

0.17 (0.28%)

06:57
04/18/19
04/18
06:57
04/18/19
06:57
Recommendations
First Solar analyst commentary  »

First Solar should be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 17

    May

PPG

PPG

$117.39

-1.01 (-0.85%)

06:57
04/18/19
04/18
06:57
04/18/19
06:57
Earnings
PPG backs FY19 adjusted EPS growth 7%-10%, consensus $6.24 »

"More broadly, we…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 18

    Apr

CTG

Computer Task Group

$4.27

0.02 (0.47%)

06:56
04/18/19
04/18
06:56
04/18/19
06:56
Earnings
Computer Task Group reports Q1 non-GAAP EPS 6c, consensus 6c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.